Conference
Extended secondary prevention with the oral direct thrombin inhibitor ximelagatran for 18 months after 6 months of anticoagulation in patients with venous thromboembolism:: A randomized, placebo-controlled trial.
Authors
Eriksson H; Wåhlander K; Lundström T; Clason SB; Schulman S
Volume
100
Pagination
pp. 81A-81A
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2002
Name of conference
44th Annual Meeting of the American-Society-of-Hematology
Conference place
PENNSYLVANIA, PHILADELPHIA
Conference start date
December 6, 2002
Conference end date
December 10, 2002
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971